70 related articles for article (PubMed ID: 20874421)
1. Loci polymorphisms of the APOBEC3G gene in HIV type 1-infected Brazilians.
Bizinoto MC; Leal E; Diaz RS; Janini LM
AIDS Res Hum Retroviruses; 2011 Feb; 27(2):137-41. PubMed ID: 20874421
[TBL] [Abstract][Full Text] [Related]
2. Absence of H186R polymorphism in exon 4 of the APOBEC3G gene among North Indian individuals.
Rathore A; Chatterjee A; Yamamoto N; Dhole TN
Genet Test; 2008 Sep; 12(3):453-6. PubMed ID: 18652534
[TBL] [Abstract][Full Text] [Related]
3. Positioning of APOBEC3G/F mutational hotspots in the human immunodeficiency virus genome favors reduced recognition by CD8+ T cells.
Monajemi M; Woodworth CF; Zipperlen K; Gallant M; Grant MD; Larijani M
PLoS One; 2014; 9(4):e93428. PubMed ID: 24722422
[TBL] [Abstract][Full Text] [Related]
4. Expression of APOBEC3G/3F and G-to-A hypermutation levels in HIV-1-infected children with different profiles of disease progression.
Amoêdo ND; Afonso AO; Cunha SM; Oliveira RH; Machado ES; Soares MA
PLoS One; 2011; 6(8):e24118. PubMed ID: 21897871
[TBL] [Abstract][Full Text] [Related]
5. Estimating the fraction of progeny virions that must incorporate APOBEC3G for suppression of productive HIV-1 infection.
Thangavelu PU; Gupta V; Dixit NM
Virology; 2014 Jan; 449():224-8. PubMed ID: 24418556
[TBL] [Abstract][Full Text] [Related]
6. APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load.
Reddy K; Winkler CA; Werner L; Mlisana K; Abdool Karim SS; Ndung'u T;
AIDS; 2010 Jan; 24(2):195-204. PubMed ID: 19996938
[TBL] [Abstract][Full Text] [Related]
7. Characterization of APOBEC3 variation in a population of HIV-1 infected individuals in northern South Africa.
Matume ND; Tebit DM; Gray LR; Turner SD; Rekosh D; Bessong PO; Hammarskjöld ML
BMC Med Genet; 2019 Jan; 20(1):21. PubMed ID: 30660178
[TBL] [Abstract][Full Text] [Related]
8. The effect of allogeneic in vitro stimulation and in vivo immunization on memory CD4(+) T-cell APOBEC3G expression and HIV-1 infectivity.
Pido-Lopez J; Wang Y; Seidl T; Babaahmady K; Vaughan R; Lehner T
Eur J Immunol; 2009 Jul; 39(7):1956-65. PubMed ID: 19585516
[TBL] [Abstract][Full Text] [Related]
9. Induction of heat-shock protein 70 by prostaglandin A₁ inhibits HIV-1 Vif-mediated degradation of APOBEC3G.
Sugiyama R; Abe M; Nishitsuji H; Murakami Y; Takeuchi H; Takaku H
Antiviral Res; 2013 Sep; 99(3):307-11. PubMed ID: 23831493
[TBL] [Abstract][Full Text] [Related]
10. Evasion of adaptive immunity by HIV through the action of host APOBEC3G/F enzymes.
Grant M; Larijani M
AIDS Res Ther; 2017 Sep; 14(1):44. PubMed ID: 28893290
[TBL] [Abstract][Full Text] [Related]
11. APOBEC3-mediated editing in HIV type 1 from pediatric patients and its association with APOBEC3G/CUL5 polymorphisms and Vif variability.
De Maio FA; Rocco CA; Aulicino PC; Bologna R; Mangano A; Sen L
AIDS Res Hum Retroviruses; 2012 Jun; 28(6):619-27. PubMed ID: 22145963
[TBL] [Abstract][Full Text] [Related]
12. Effect of HIV-1 Vif variability on progression to pediatric AIDS and its association with APOBEC3G and CUL5 polymorphisms.
De Maio FA; Rocco CA; Aulicino PC; Bologna R; Mangano A; Sen L
Infect Genet Evol; 2011 Aug; 11(6):1256-62. PubMed ID: 21571098
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants in the host restriction factor APOBEC3G are associated with HIV-1-related disease progression and central nervous system impairment in children.
Singh KK; Wang Y; Gray KP; Farhad M; Brummel S; Fenton T; Trout R; Spector SA
J Acquir Immune Defic Syndr; 2013 Feb; 62(2):197-203. PubMed ID: 23138837
[TBL] [Abstract][Full Text] [Related]
14. Coding region variant 186H/R in Exon 4 of APOBEC3G among individuals of Western India.
Singh H; Marathe S; Nain S; Nema V; Angadi M; Bapat S; Pawar J; Ghate M; Sahay S; Gangakhedkar RR
APMIS; 2016 May; 124(5):401-5. PubMed ID: 26853443
[TBL] [Abstract][Full Text] [Related]
15. A naturally occurring Vif mutant (I107T) attenuates anti-APOBEC3G activity and HIV-1 replication.
Peng J; Ao Z; Matthews C; Wang X; Ramdahin S; Chen X; Li J; Chen L; He J; Ball B; Fowke K; Plummer F; Embree J; Yao X
J Mol Biol; 2013 Aug; 425(16):2840-52. PubMed ID: 23707381
[TBL] [Abstract][Full Text] [Related]
16. The level of APOBEC3G (hA3G)-related G-to-A mutations does not correlate with viral load in HIV type 1-infected individuals.
Ulenga NK; Sarr AD; Hamel D; Sankale JL; Mboup S; Kanki PJ
AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1285-90. PubMed ID: 18851679
[TBL] [Abstract][Full Text] [Related]
17. APOBEC3G genetic variants and their influence on the progression to AIDS.
An P; Bleiber G; Duggal P; Nelson G; May M; Mangeat B; Alobwede I; Trono D; Vlahov D; Donfield S; Goedert JJ; Phair J; Buchbinder S; O'Brien SJ; Telenti A; Winkler CA
J Virol; 2004 Oct; 78(20):11070-6. PubMed ID: 15452227
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 subtype variability in Vif derived from molecular clones affects APOBEC3G-mediated host restriction.
Lisovsky I; Schader SM; Sloan RD; Oliveira M; Coutsinos D; Bernard NF; Wainberg MA
Intervirology; 2013; 56(4):258-64. PubMed ID: 23689841
[TBL] [Abstract][Full Text] [Related]
19. CUL5 and APOBEC3G Polymorphisms are Partially Implicated in HIV-1 Infection and Antiretroviral Therapy in a Brazilian Population.
da Silva RC; Coelho AVC; de Moura RR; Arraes LC; Brandão LAC; Guimarães RL; Crovella S
Curr HIV Res; 2017; 15(4):245-257. PubMed ID: 28302043
[TBL] [Abstract][Full Text] [Related]
20. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
He Z; Zhang W; Chen G; Xu R; Yu XF
J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]